Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Therapeutic Vaccines for Ovarian Cancer
Stephanie Chow, Jonathan S. Berek, Oliver Dorigo
Vaccines (2020) Vol. 8, Iss. 4, pp. 657-657
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4438-4438
Open Access | Times Cited: 58
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
Jagadeeswara Rao Bommi, Shekher Kummari, Kavitha Lakavath, et al.
Biosensors (2023) Vol. 13, Iss. 3, pp. 398-398
Open Access | Times Cited: 30
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 13
Innovative landscapes in intraperitoneal therapy of ovarian cancer
K. Kumar, M. S. Madhusoodanan, Meghna Pangath, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fučíková, An Coosemans, Sandra Oršulić, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e002873-e002873
Open Access | Times Cited: 46
Adoptive T cell therapy for ovarian cancer
Sarah B. Gitto, Chibuike Ihewulezi, Daniel J. Powell
Gynecologic Oncology (2024) Vol. 186, pp. 77-84
Closed Access | Times Cited: 8
Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
Won-Hee Yoon, Anna deFazio, Lawrence Kasherman
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 358-377
Open Access | Times Cited: 14
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
Hongli Wang, Zhi‐Gang Wang, Shu‐Lin Liu
Molecules (2022) Vol. 27, Iss. 17, pp. 5607-5607
Open Access | Times Cited: 22
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L. Disis, Sarah F. Adams, Jyoti Bajpai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006624-e006624
Open Access | Times Cited: 13
Vaccination and personalized cancer vaccines focusing on common cancers in women: a narrative review
Seyed Sadeq Mousavi Ghahfarrokhi, Pegah Karimi, Fateme-Sadat Mahdigholi, et al.
Pathology - Research and Practice (2025) Vol. 270, pp. 155983-155983
Closed Access
From Defense to Disease: How the Immune System Fuels Epithelial–Mesenchymal Transition in Ovarian Cancer
Michał Kos, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4041-4041
Open Access
Cell therapies in ovarian cancer
Apostolos Sarivalasis, Matteo Morotti, Arthur Mulvey, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 27
GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions
Riccardo Di Fiore, Sherif Suleiman, Bridget Ellul, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 493-493
Open Access | Times Cited: 26
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Simav Gildiz, Tamara Minko
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 123-144
Open Access | Times Cited: 17
Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation
Parul Grover, Kulbhushan Thakur, Monika Bhardwaj, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 12, pp. 1050-1074
Closed Access | Times Cited: 3
RNA-lipid nanoparticle therapeutics for women’s health
Alireza Nomani, Aishwarya Saraswat, Yu Zhang, et al.
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Development of a nano-vaccine for high-grade serous ovarian cancer
Chayanika Saha, Ahmed Elkashif, Elaine S. Gilmore, et al.
Biomaterials Science (2025)
Open Access
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
(2021)
Open Access | Times Cited: 21
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox
Sara Moufarrij, Roisin E. O’Cearbhaill
Current Oncology (2023) Vol. 31, Iss. 1, pp. 97-114
Open Access | Times Cited: 8
Efficacy and safety of neoadjuvant chemotherapy containing anti-angiogenic drugs, immunotherapy, or PARP inhibitors for ovarian cancer
Wanying Bao, Zhengyu Li
Critical Reviews in Oncology/Hematology (2023) Vol. 194, pp. 104238-104238
Closed Access | Times Cited: 7
Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategies
Joanna Kefas, Michael Flynn
Cancer Drug Resistance (2024)
Open Access | Times Cited: 2
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2362-2362
Open Access | Times Cited: 11
Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers
Tetiana Korzun, Abraham S. Moses, Parham Diba, et al.
Small (2023)
Closed Access | Times Cited: 5
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial
Oliver Dorigo, Amit M. Oza, Tanja Pejović, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 15, pp. 2808-2815
Open Access | Times Cited: 4
Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
Jiřina Bartůňková
Onco (2024) Vol. 4, Iss. 1, pp. 46-55
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top